New Information about Mesothelioma Diagnosis and Treatment at Memorial Sloan-Kettering
Most oncologists see very few people with mesothelioma, a relatively rare cancer. The illness originates in a membrane called the mesothelium, which forms a lining that protects many of the body’s internal organs. It has been linked to exposure to asbestos once commonly used in building materials and is diagnosed in just 2,000 to 3,000 people in the United States each year.
Gene Mutation Linked to Inherited Risk of Common Form of Childhood Leukemia
A new international study led by physicians and scientists from Memorial Sloan-Kettering has discovered a gene mutation linked with a rare inherited form of childhood acute lymphoblastic leukemia (ALL), the most common cancer occurring in children. The finding could potentially be used to prevent ALL in leukemia-prone families by prenatal testing. Read more>
Matthew S. Katz, MD, is the Medical Director of Radiation Oncology at Lowell General Hospital and a partner in Radiation Oncology Associates, PA. He is an Instructor at Harvard Medical School and former Chair of Communications Committee for the American Society for Radiation Oncology (ASTRO). He serves on the Communications Committee for Massachusetts Medical Society and external advisory board for Mayo Clinic’s Center for Social Media. His areas of prime interest are patient education and health empowerment. Connect with Matt via Twitter at @s...
Comparison of Drugs for Advanced Kidney Cancer Suggests Side Effects Are More Manageable with Newer Option
For the past seven years, the leading targeted drug for advanced kidney cancer has offered longer survival for patients with this disease, which often is difficult to treat. But recent multinational research led by Memorial Sloan-Kettering that directly compared this drug with a newer one has indicated that while the two medications have similar benefits for disease control, the newer drug has less-troublesome side effects.
Caring for Your Skin during and after Cancer Treatment
As the body’s first line of defense against sunlight, chemicals, and infectious germs, the skin is also one of the areas of the body most commonly affected by treatments for cancer.Read full article in Center News>